Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impact on the company's financial results. Still, ...

A recent study found that $1 million in retirement savings can last a whopping 95 years in Cuenca, Ecuador; annual expenses ...

No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading ...

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.

Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, driven by AI systems that deliver laboratory-grade results at the bedside [1].

Medtronic (NYSE: MDT) today announced new data demonstrating the health economic benefits of its MiniMed 780G system.

Automated insulin delivery systems can help pregnant women with type 1 diabetes manage their glucose during gestation.

December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...

The stock's rise snapped a three-day losing streak.

Medtronic has announced that Ryan Weispfenning, vice president and head of investor relations, will join its diabetes business to establish and lead the investor relations function ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...